Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 12:59 AM
NCT ID:
NCT04405193
Eligibility Criteria:
Inclusion Criteria:
* Men or women, 18 - 60 years old
* Diagnosed with methamphetamine addiction based on DSM-V criteria, enrolling for methamphetamine withdrawal treatment
* Agree to participate in the trial by signing informed consent
Exclusion Criteria:
* Known hypersensitivity to N-acetylcysteine
* Patients with serious conditions that will not allow protocol compliance or safe participation in the clinical trials.
* Pregnant or breastfeeding women
* History of suicidal thoughts / behaviour
* History of N-acetylcysteine treatment
* History of asthma and convulsions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04405193
Study Brief:
Protocol Section:
NCT04405193